Sensitivity of human immunodeficiency virus infection to various α, β and γ chemokines

Journal of General Virology

Volumn 80, Issue 9, 1999, Pages 2369-2373

  Greco, Giampaolo ^a   Mackewicz, Carl ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; GAMMA CHEMOKINE; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0032856594     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-9-2369     Document Type: Article

References (21)

1. Adams, D. H. & Lloyd, A. R. (1997). Chemokines: leucocyte recruitment and A activation cytokines. Lancet 349, 490-495.
2. Barker, E., Mackewicz, C. E., Reyes-Teran, G., Sato, A., Stranford, S. A., Fujimura, S. H., Christopherson, C., Chang, S. Y. & Levy, J. A. (1998). Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared to those who have progressed to acquired immunodeficiency syndrome. Blood 92, 1-11.
3. Berger, E. A. (1997). HIV entry and tropism: the chemokine receptor connection. AIDS 11, 3-16.
4. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. & Lusso, P. (1995). Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8 + T cells. Science 270, 1811-1815.
5. Dolei, A., Biolchini, A., Serra, C., Curreli, S., Gomes, E. & Dianzani, F. (1998). Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS 12, 183-190.
6. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
7. Frade, J. M. R., Llorente, M., Mellado, M., Alcami, J., Gutierrez-Ramos, J. C., Zaballos, A., del Real, G. & Martinez-A., C. (1997). The amino-terminal domain of the CCR2 chemokine receptor acts as a coreceptor for HIV-1 infection, Journal of Clinical Investigation 100, 497-502.
8. Gong, W., Howard, O. M., Turpin, J. A., Grimm, M. C., Ueda, H., Gray, P. W., Raport, C. J., Oppenheim, J. J. & Wang, J. M. (1998). Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. Journal of Biological Chemistry 273, 4289-4292.
9. Hoffman, A. D., Banapour, B. & Levy, J. A. (1985). Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147, 326-335.
10. Kinter, A., Catanzaro, A., Monaco, J., Ruiz, M., Justement, J., Moir, S., Arthos, J., Oliva, A., Ehler, L., Mizell, S., Jackson, R., Ostrowski, M., Hoxie, J., Offord, R. & Fauci, A. S. (1998). CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+)T cells: role of signal transduction. Proceedings of the National Academy of Sciences, USA 95, 11880-11885.
11. Landay, A. L., Mackewicz, C. & Levy, J. A. (1993). An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clinical Immunology and Immunopathology 69, 106-116.
12. Lee, B., Doranz, B. J., Rana, S., Yi, Y., Mellado, M., Frade, J. M., Martinez-A., C., O'Brien, S. J., Dean, J., Collman, R. G. & Doms, R. W. (1998). Influence of the CCR2-V641 polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. Journal of Virology 72, 7450-7458.
13. Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M. & Oshiro, L. S. (1984). Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225, 840-842.
14. McDougal, J. S., Cort, S. P., Kennedy, M. S., Cabridilla, C. D., Feorino, P. M., Francis, D. P., Hicks, D., Kalyanaraman, V. S. & Martin, L. S. (1985). Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). Journal of Immunological Methods 76, 171-183.
15. Mackewicz, C. E., Ortega, H. W. & Levy, J. A. (1991). CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. Journal of Clinical Investigation 87, 1462-1466.
16. Mackewicz, C. E., Barker, E. & Levy, J. A. (1996). Role of β-chemokines in suppressing HIV replication. Science 274, 1393-1395.
17. Pal, R., Garzino-Demo, A., Markham, P. D., Murns, J., Brown, M., Gallo, R. C. & DeVico, A. L. (1997). Inhibition of HIV-1 infection by β-chemokine MDC. Science 278, 695-698.
18. Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J. F., Yi, Y., Smyth, R. J., Collman, R. G., Broder, C. C., Vassart, G., Doms, R. W. & Parmentier, M. (1996). Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87, 437-446.
19. Schols, D., Proost, P., Van Damme, J. & De Clercq, E. (1997). RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE). Journal of Virology 71, 7300-7304.
20. Trkola, A., Paxton, W. A., Monard, S. P., Hoxie, J. A., Siani, M. A., Thompson, D. A., Wu, L., Mackay, C. R., Horuk, R. & Moore, J. P. (1998). Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. Journal of Virology 72, 396-404.
21. Yoshida, R., Nagira, M., Kitaura, M., Imagawa, N., Imai, T. & Yoshie, O. (1998). Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. Journal of Biological Chemistry 273, 7118-7122.